Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
The EPO Boards of Appeal have revoked several patents belonging to Nevro, following oppositions from competitors Boston Scientific and Medtronic. While two of the companies had previously settled all
The European Patent Office (EPO) and Brazil’s National Institute of Industrial Property (INPI) have recently reaffirmed their commitment to strengthening cooperation in the field of patents. This
The court rejected Moderna’s requests to decline jurisdiction (case IDs: UPC_CFI_191/2025 and UPC_CFI_192/2025). All three countries are EPO states but are not participating in the UPC. Poland and Spain
proceedings in Germany will continue this summer. CureVac is defending several patents at the EPO and before national civil courts in Germany and UK. At the center of the current dispute are EP 3 708
giving UPC representatives the definitive guidance that it’s their responsibility to keep track of European Patent Office (EPO) case law (Technical Boards of Appeal (TBAs) and Enlarged Board of Appeal
thin silicon layer. According to the institute, this enables excellent charge carrier selectivity, increasing cell efficiency and performance even in poor lighting conditions. The EPO’s Opposition
Patent applications originating from China at the European Patent Office (EPO) grew by 29.2 percent in 2019, the highest growth rate among the ten leading patent filing countries, to 12,247
Chinese companies and inventors filed a record high of 19,041 patent applications at the European Patent Office (EPO), up 15.1%, the highest among the 20 major patent filing countries, according to
FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid, the office said on Tuesday, handing a win to BioNTech (22UAy.DE) and its pa...
The EPO’s Technical Boards of Appeal rejected the application due to added matter objections (case ID: T1515/20). Thus, the EPO granted EP 888 on 1 May 2024 with claims defined in terms of the
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
